Parallel Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-928
| Closed | -$153K | – | 3413 |
|
|
2021
Q2 | $153K | Buy |
928
+690
| +290% | +$115K | 0.01% | 798 |
|
|
2021
Q1 | $36K | Sell |
238
-2,149
| -90% | -$292K | ﹤0.01% | 1330 |
|
|
2020
Q4 | $299K | Hold |
2,387
| – | – | 0.02% | 461 |
|
|
2020
Q3 | $242K | Buy |
2,387
+16
| +0.7% | +$1.63K | 0.02% | 496 |
|
|
2020
Q2 | $230K | Buy |
2,371
+33
| +1% | +$3.07K | 0.02% | 494 |
|
|
2020
Q1 | $194K | Sell |
2,338
-128
| -5% | -$12.5K | 0.02% | 451 |
|
|
2019
Q4 | $274K | Hold |
2,466
| – | – | 0.02% | 416 |
|
|
2019
Q3 | $245K | Buy |
2,466
+57
| +2% | +$5.66K | 0.02% | 420 |
|
|
2019
Q2 | $239K | Buy |
2,409
+605
| +34% | +$57.7K | 0.02% | 393 |
|
|
2019
Q1 | $199K | Hold |
1,804
| – | – | 0.02% | 405 |
|
|
2018
Q4 | $165K | Hold |
1,804
| – | – | 0.02% | 411 |
|
|
2018
Q3 | $199K | Buy |
1,804
+1,629
| +931% | +$170K | 0.02% | 385 |
|
|
2018
Q2 | $16K | Sell |
175
-4
| -2% | -$344 | ﹤0.01% | 1158 |
|
|
2018
Q1 | $15K | Sell |
179
-7
| -4% | -$622 | ﹤0.01% | 1123 |
|
|
2017
Q4 | $17K | Hold |
186
| – | – | ﹤0.01% | 1093 |
|
|
2017
Q3 | $15K | Sell |
186
-5
| -3% | -$378 | ﹤0.01% | 1129 |
|
|
2017
Q2 | $14K | Buy |
191
+5
| +3% | +$347 | ﹤0.01% | 1178 |
|
|
2017
Q1 | $12K | Buy |
+186
| New | +$11K | ﹤0.01% | 1162 |
|
Other funds holding PRAH
Parallel Advisors's PRAH Position: Q3 2021 in Review
Parallel Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 928 shares — an estimated $153K sold.
Parallel Advisors first reported a position in PRAH in Q1 2017 and held it in 18 quarters. The position peaked at $299K in Q4 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Parallel Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Parallel Advisors sold 928 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $153K.
- Parallel Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 18 quarters.
- Parallel Advisors's PRA Health Sciences, Inc. position peaked at $299K in Q4 2020.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.